Therapeuticsmd Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for THERAPEUTICSMD INC, and what generic alternatives to THERAPEUTICSMD INC drugs are available?
THERAPEUTICSMD INC has two approved drugs.
There are twenty-seven US patents protecting THERAPEUTICSMD INC drugs.
There are one hundred and fifty-three patent family members on THERAPEUTICSMD INC drugs in twenty-two countries and thirty-eight supplementary protection certificates in fourteen countries.
Summary for Therapeuticsmd Inc
International Patents: | 153 |
US Patents: | 27 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Drugs and US Patents for Therapeuticsmd Inc
International Patents for Therapeuticsmd Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2861233 | See Plans and Pricing |
Russian Federation | 2016136666 | See Plans and Pricing |
Australia | 2019204658 | See Plans and Pricing |
Japan | 2017509630 | See Plans and Pricing |
South Korea | 20180100567 | See Plans and Pricing |
Japan | 6397402 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Therapeuticsmd Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | 15C0050 | France | See Plans and Pricing | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
2782584 | LUC00245 | Luxembourg | See Plans and Pricing | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210701 |
0771217 | CA 2006 00038 | Denmark | See Plans and Pricing | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
0770388 | SPC/GB09/026 | United Kingdom | See Plans and Pricing | PRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208 |
0771217 | 07C0001 | France | See Plans and Pricing | PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804 |
2782584 | 301153 | Netherlands | See Plans and Pricing | PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.